Apellis Pharmaceuticals, Inc. APLS
41.03 USD 0.00 0.00%
At close · May 15
41.06 +0.03 +0.07%
After hours · May 15, 4:00 PM ET
16.83 52-week range 41.14
- YTD
- +63.34%
- 1 year
- +150.79%
- Open
- 41.05
- Prev close
- 41.03
- Mkt cap
- 5.25B
- Vol
- 28.64M
- Avg vol
- 7.54M
- EPS
- 1.02
- P/E
- 38.71
- Div yield
- 0.00%
More statistics
- Low
- 41.03
- High
- 41.05
- Beta
- -0.25
- Inst. own
- 110.43%
- Dividend
- 0.00
- Earnings
- Jul 30, 2026
MAX chart
Chart tools
Chart is warming up
The all-time price history for APLS has not been loaded yet. Try again in a moment.
Altman Z-Score
3.24 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 140×
P/S 3.2×
P/B 8.6×
P/FCF 70.3×
EV/EBITDA 45.5×
EV/Sales 3.2×
FCF Yield 1.4%
Gross Margin 89.8%
Operating Margin 5.5%
Net Margin 2.2%
ROE 6.0%
ROIC 6.0%
ROA 2.1%
Revenue 28.5%
Operating Income 133.6%
EPS (diluted) 111.3%
Free Cash Flow 151.0%
Current Ratio 3.1×
Quick Ratio 2.7×
Debt / Equity 1.3×
Net Debt / EBITDA 0.3×
Interest Coverage 1.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31